TESTING PROCESS
    1.
    发明申请
    TESTING PROCESS 审中-公开
    测试过程

    公开(公告)号:US20120253685A1

    公开(公告)日:2012-10-04

    申请号:US13431174

    申请日:2012-03-27

    IPC分类号: G06F19/20 G06F19/00

    摘要: A method of determining an inclusive residual risk that a pregnancy is affected by at least one phenotypic disorder included in a disorder set is provided. The method includes calculating a prior risk for a disorder set, calculating posterior risks for the individual disorders or groups of disorders in the disorder set that can be screened for and/or diagnosed prenatally, and calculating an inclusive residual risk for the disorder set by combining the prior risks for disorders for which no tests have been performed and the individual posterior risks.

    摘要翻译: 提供了一种确定怀孕受包括在病症组中的至少一种表型障碍影响的包容性残留风险的方法。 该方法包括计算病情集合的先前风险,计算可以筛选和/或诊断出的疾病组中的个体病症或病症组的后验风险,以及通过组合计算所述病症的包容性残留风险 以前没有进行检查的疾病和个体后遗症的风险。

    Testing Process
    2.
    发明申请
    Testing Process 审中-公开
    测试过程

    公开(公告)号:US20090036748A1

    公开(公告)日:2009-02-05

    申请号:US11850314

    申请日:2007-09-05

    IPC分类号: A61B5/00 G06F19/00 C12Q1/68

    摘要: A method of determining an inclusive residual risk that a pregnancy is affected by at least one phenotypic disorder included in a disorder set is provided. The method includes calculating a prior risk for a disorder set, calculating posterior risks for the individual disorders or groups of disorders in the disorder set that can be screened for and/or diagnosed prenatally, and calculating an inclusive residual risk for the disorder set by combining the prior risks for disorders for which no tests have been performed and the individual posterior risks.

    摘要翻译: 提供了确定怀孕受到包含在病症组中的至少一种表型障碍影响的包容性残留风险的方法。 该方法包括计算病情集合的先前风险,计算可以筛选和/或诊断出的疾病组中的个体病症或病症组的后验风险,以及通过组合计算所述病症的包容性残留风险 以前没有进行检查的疾病和个体后遗症的风险。

    Method and apparatus for characterizing solutions of small particles
    3.
    发明申请
    Method and apparatus for characterizing solutions of small particles 有权
    表征小颗粒溶液的方法和装置

    公开(公告)号:US20070155017A1

    公开(公告)日:2007-07-05

    申请号:US11707835

    申请日:2007-02-16

    申请人: Philip Wyatt

    发明人: Philip Wyatt

    IPC分类号: G01N35/00

    摘要: A method and apparatus is described by which means molecules in suspension may be characterized in terms of the size and mass distributions present. As a sample solution is separated by centrifugal means, it is illuminated at a particular radial distance from the axis of rotation by a fine, preferably monochromatic, light beam. Despite the high resolution of such devices, a key problem associated with most separators based upon use of centrifugal forces is the difficulty in deriving the absolute size and/or molar. mass of the separating molecules. By integrating means to detect light scattered, over a range of scattering angles, from samples undergoing centrifugal separation, molecular sizes in the sub-micrometer range may be derived, even in the presence of diffusion. Adding a second light beam at a displaced rotational angle, preferably of an ultraviolet wavelength, that intersects the sample at the same radial region as the first beam permits determination of the molecular concentration at that region. Combining the light scattering data with the associated concentration permits the determination of the associated molar mass. In a preferred embodiment, the light beam and detectors may be controlled to scan synchronously the sample radially during separation.

    摘要翻译: 通过这种方法和装置来描述悬浮液中的分子可以根据存在的大小和质量分布进行表征。 当通过离心装置分离出样品溶液时,它通过精细的,优选单色的光束在距旋转轴的特定径向距离处被照射。 尽管这种装置的高分辨率,但是基于使用离心力的大多数分离器所关联的关键问题是导出绝对大小和/或摩尔数的困难。 分离分子的质量。 通过积分手段来检测在离散分离的样品的散射角范围内的光,即使在扩散存在的情况下也可以导出亚微米范围内的分子尺寸。 以与第一光束相同的径向区域与样品相交的位移旋转角度(优选为紫外线波长)添加第二光束允许确定该区域处的分子浓度。 将光散射数据与相关浓度相结合可以确定相关的摩尔质量。 在优选实施例中,可以控制光束和检测器在分离期间径向地同步扫描样品。

    Medicament Administration Apparatus
    6.
    发明申请
    Medicament Administration Apparatus 审中-公开
    药物管理器具

    公开(公告)号:US20130289530A1

    公开(公告)日:2013-10-31

    申请号:US13908387

    申请日:2013-06-03

    IPC分类号: A61J1/20

    摘要: An apparatus for removal of premixed drugs or reconstitution of lyophilized drugs and for the injection of the reconstituted drug into the patient. The apparatus includes a syringe assembly and an adapter assembly that can be removably connected to a medicament container containing a premixed drug or lyophilized medicament. The syringe assembly of the apparatus includes a liquid chamber between the forward end of the body portion and the piston and a syringe cannula assembly. The syringe cannula assembly, which can be removably interconnected with the body portion, comprises a cannula support and a hypodermic needle sealably connected to the cannula support. The adapter assembly comprises an adapter preferably molded from a moldable plastic that includes a top wall, an adapter cannula connected to and extending from the top wall and a variety of connectors connected to the top wall for removably interconnecting the adapter with the medicament container.

    摘要翻译: 用于去除预混合药物或重构冻干药物并将重构药物注射入患者的装置。 该装置包括注射器组件和适配器组件,其可拆卸地连接到含有预混合药物或冻干药物的药物容器。 该装置的注射器组件包括在主体部分的前端和活塞之间的液体室和注射器套管组件。 可拆卸地与主体部分相互连接的注射器套管组件包括插管支架和可密封地连接到套管支撑件的皮下注射针。 适配器组件包括适配器,其优选地由可模制塑料模制,其包括顶壁,连接到顶壁并从顶壁延伸的适配器插管和连接到顶壁的各种连接器,用于将适配器可拆卸地互连到药物容器。

    FLUE SYSTEM FOR STORAGE RACKS
    7.
    发明申请
    FLUE SYSTEM FOR STORAGE RACKS 有权
    用于储存架的FLUE系统

    公开(公告)号:US20070175371A1

    公开(公告)日:2007-08-02

    申请号:US11670641

    申请日:2007-02-02

    IPC分类号: F23M9/00

    CPC分类号: A47B47/027 A47B55/02 A47F5/01

    摘要: A storage rack includes at least one first support beam at a first end of the storage rack and at least one second support beam at a second, opposite end of the storage rack wherein the support beams are spaced apart to define a storage area. A flue system for use with the storage rack includes first and second brackets. The first bracket is coupled to the first support beam and the second bracket is coupled to the second support beam. The first side panel extends between the first and second ends of the storage rack, and includes a first end removably coupled to the first bracket and a second end removably coupled to the second bracket. A second side panel extends between the first and second ends of the storage rack, and includes a first end removably coupled to the first bracket and a second end removably coupled to the second bracket. The first and second side panels are spaced apart to define a passageway extending through the storage rack.

    摘要翻译: 存储架包括在存储架的第一端处的至少一个第一支撑梁和在存储架的第二相对端处的至少一个第二支撑梁,其中支撑梁间隔开以限定存储区域。 用于存储架的烟道系统包括第一和第二支架。 第一支架联接到第一支撑梁并且第二支架联接到第二支撑梁。 所述第一侧面板在所述存放架的所述第一和第二端之间延伸,并且包括可移除地联接到所述第一支架的第一端和可移除地联接到所述第二支架的第二端。 第二侧面板在储存架的第一和第二端之间延伸,并且包括可移除地联接到第一支架的第一端和可移除地联接到第二支架的第二端。 第一和第二侧板间隔开以限定延伸穿过存放架的通道。

    Medicament administration apparatus
    8.
    发明申请
    Medicament administration apparatus 审中-公开
    药物管理器具

    公开(公告)号:US20050137523A1

    公开(公告)日:2005-06-23

    申请号:US10744806

    申请日:2003-12-22

    摘要: An apparatus for removal of premixed drugs or reconstitution of lyophilized drugs and for the injection of the reconstituted drug into the patient. The apparatus includes a syringe assembly and an adapter assembly that can be removably connected to a medicament container containing a premixed drug or lyophilized medicament. The syringe assembly of the apparatus includes a body portion to form a liquid chamber between the forward end of the body portion and the piston and a syringe cannula assembly. The syringe cannula assembly, which can be removably interconnected with the body portion, comprises a cannula support and a hypodermic needle sealably connected to the cannula support. The adapter assembly comprises an adapter preferably molded from a moldable plastic that includes a top wall, an adapter cannula connected to and extending from the top wall and a variety of connectors connected to the top wall for removably interconnecting the adapter with the medicament container. The adapter assembly further includes syringe connector member connected to the top wall for removably interconnecting the syringe with the adapter in a manner to uniquely position the syringe cannula within the lumen of the adapter cannula wherein it is completely shielded from external contamination and prevent print damage and injury to the user.

    摘要翻译: 用于去除预混合药物或重构冻干药物并将重构药物注射入患者的装置。 该装置包括注射器组件和适配器组件,其可拆卸地连接到含有预混合药物或冻干药物的药物容器。 该装置的注射器组件包括主体部分,以在主体部分的前端和活塞之间形成液体室和注射器插管组件。 可拆卸地与主体部分相互连接的注射器套管组件包括插管支架和可密封地连接到套管支撑件的皮下注射针。 适配器组件包括适配器,其优选地由可模制塑料模制,其包括顶壁,连接到顶壁并从顶壁延伸的适配器插管和连接到顶壁的各种连接器,用于将适配器可拆卸地互连到药物容器。 适配器组件还包括连接到顶壁的注射器连接器构件,用于将注射器与适配器可移除地互连,以将注射器套管唯一地定位在适配器插管的内腔内,其中完全屏蔽外部污染并防止印刷损伤, 对用户造成伤害

    Medicament Administration Apparatus
    10.
    发明申请

    公开(公告)号:US20160051447A1

    公开(公告)日:2016-02-25

    申请号:US14933817

    申请日:2015-11-05

    IPC分类号: A61J1/20

    摘要: An apparatus for removal of premixed drugs or reconstitution of lyophilized drugs and for the injection of the reconstituted drug into the patient. The apparatus includes a syringe assembly and an adapter assembly that can be removably connected to a medicament container containing a premixed drug or lyophilized medicament. The syringe assembly of the apparatus includes a liquid chamber between the forward end of the body portion and the piston and a syringe cannula assembly. The syringe cannula assembly, which can be removably interconnected with the body portion, comprises a cannula support and a hypodermic needle sealably connected to the cannula support. The adapter assembly comprises an adapter preferably molded from a moldable plastic that includes a top wall, an adapter cannula connected to and extending from the top wall and a variety of connectors connected to the top wall for removably interconnecting the adapter with the medicament container.